IndiaFilingsIndiaFilings
India FlagRegister India Company
UAE FlagRegister UAE Company
USA FlagRegister USA Company

DR. CURE AND CARE LLP

LLPIN : AAG-0198|ROC: RoC-DelhiActive
Last Updated On : 18-03-2024
LLPINAAG-0198
LLP NameDR. CURE AND CARE LLP
Number of Partners2
Number of Designated Partners2
ROC CodeRoC-Delhi
Date of Incorporation22-03-2016
Registered Address2E4, Jhandewalan Extension NA New Delhi New Delhi Delhi 110055
Email IDvikaswahi99@gmail.com
Total Obligation of Contribution1,00,000
Main division of business activity to be carried out in India74
Description of main divisionOther Business Activities
Date of last financial year end for Statement of Accounts and Solvency2023-03-31
Date of last financial year end for Annual Return filed31-03-2023
LLP StatusActive

Directors / Signatory Details

DIN / PANNameBegin Date
00704677VIKAS WAHI22-03-2016
07440841VAISHNAVI WAHI22-03-2016
DR. CURE AND CARE LLP is a Limited Liability Partnership (LLP) governed by the LLP Act, 2008. Registered under the Registrar of Companies RoC-Delhi, it operates as a non-government entity. According to the Ministry of Corporate Affairs (MCA), this LLP was incorporated on 22-03-2016 and last updated on 18-03-2024. Its LLP Identification Number (LLPIN) is , and the registration number is . Currently, its eFiling status is listed as “Active” as per MCA records.
From a financial standpoint, DR. CURE AND CARE LLP has a total contribution of INR 1,00,000. Details of the latest financial filings, such as the Statement of Accounts and Solvency or Annual Returns, are unavailable, indicating limited publicly disclosed financial data.
The registered office address is 2E4, Jhandewalan Extension NA New Delhi New Delhi Delhi 110055. Correspondence or inquiries may be sent to the official email address, vikaswahi99@gmail.com.
For those interested in further details, below are some frequently asked questions:
Disclaimer

IndiaFilings is not affiliated with any companies listed on this website and does not represent them. Please contact the respective company directly for their inquiries.